VOO

Purple Biotech’s “Capping” Technology Enables 300× Higher Dosing in Cancer Immunotherapy (NASDAQ: PPBT)

WSW, NY, 20th January 2026, FinanceWire … Read More

Actelis Networks Is Tapping Into a Growing Wave of Smart City Infrastructure Investment (NASDAQ: ASNS)

WSW, NY, 19th January 2026, FinanceWire … Read More

Palatin Technologies Targets Hypothalamic Obesity as Next Frontier Beyond GLP-1s (NYSE: PTN)

WSW, NY, 12th January 2026, FinanceWire … Read More

MediWound’s Enzymatic Burn Therapy Deployed After New Year’s Tragedy in Switzerland (NASDAQ: MDWD)

WSW, NY, 2nd January 2026, FinanceWire … Read More

Actelis Networks is Helping America Modernize its Aging Infrastructure, While Chinese Hackers Continue to Target It (NASDAQ: ASNS)

WSW, NY, 29th December 2025, FinanceWire … Read More

Nasus Pharma Receives $19 Price Target and ‘Market Outperform’ Rating From Citizens Analyst

WSW, NY, 18th December 2025, FinanceWire … Read More

Nuvectis Pharma’s New Phase 1b Trial Targets a Major Lung Cancer Bottleneck (NASDAQ: NVCT)

WSW, NY, 17th December 2025, FinanceWire … Read More

Silexion Therapeutics Receives $6 Price Target and Buy Rating From Litchfield Hills Research (NASDAQ: SLXN)

WSW, NY, 15th December 2025, FinanceWire … Read More

InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR)

WSW, NY, 12th December 2025, FinanceWire … Read More

Inspira Technologies May be Perfectly Positioned as Flu Cases Increase and Respiratory Complexity Grows (NASDAQ: IINN)

WSW, NY, 11th December 2025, FinanceWire … Read More